Orchestra BioMed (Nasdaq:OBIO) announced updated expectations for the timeline of its BACKBEAT cardiac pacing clinical trial.

A novel leadless pacemaker designed for left bundle branch area pacing conferred successful pacing parameters at 1 month, but ...

Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...

Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...

Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

Estimates suggest that around three million Americans are living with cardiac pacemakers, according to the American Heart Association. Now, thanks to MountainStar Healthcare, a new kind of pacemaker – ...

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...

The cardiac pacemaker harmlessly dissolves over the course of 35 days. (Courtesy: Northwestern University) Temporary cardiac pacemakers provide essential pacing for patients with short-term heart ...

Heart problems are nothing new. Humans have been fascinated by electrocardiography since the era of Hippocrates (via St. Luke's Hospital Cardiology Department). With each passing century, medicine's ...

The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...